A Study of JNJ-73763989 in Adult Participants With Renal Impairment

Inclusion Criteria: * Must have stable renal function defined as a less than (\<) 20 percent (%) change in serum creatinine concentrations between screening and Day -1 * Concomitant medications should be stable for the previous 1 month and throughout the duration of the study * Women, except for postmenopausal women, must have a negative highly sensitive serum (beta-human chorionic gonadotropin \[beta-hCG\]) at screening and urine (beta-hCG) pregnancy test on Day -1 * Must sign an informed consent form (ICF) indicating they understand the purpose of, and procedures required for the study and are willing to participate in the study * Participants with kidney disease without dialysis using benzodiazepines, tricyclic antidepressants, and prescription opiates with a positive urine test for drugs prescribed by their physician may be included following prior discussion with the sponsor Exclusion Criteria: * Have kidney disease requiring dialysis * Renal transplants, systemic lupus erythematosus, or participant with malignancy * Known allergies, hypersensitivity, or intolerance to JNJ-73763989 or its excipients * Received an experimental drug (including investigational vaccines) or used an experimental medical device within 1 month or within a period less than 10 times the drug's half-life, whichever is longer, before the administration of the study drug is scheduled * Preplanned surgery or procedures that would interfere with the conduct of the study